GWSG
PBYI icon

GPS Wealth Strategies Group’s Puma Biotechnology PBYI Stock Holding History

GPS Wealth Strategies Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.95K Hold
1,000
– – 0.01% 449
2025
Q3 		$5.31K Hold
1,000
– – ﹤0.01% 1246
2025
Q2 		$3.43K Hold
1,000
– – ﹤0.01% 1283
2025
Q1 		$2.96K Hold
1,000
– – ﹤0.01% 1253
2024
Q4 		$3.05K Hold
1,000
– – ﹤0.01% 1180
2024
Q3 		$2.55K Hold
1,000
– – ﹤0.01% 1206
2024
Q2 		$3.26K Hold
1,000
– – ﹤0.01% 1148
2024
Q1 		$5.3K Hold
1,000
– – ﹤0.01% 990
2023
Q4 		$4.33K Buy
+1,000
New +$3.31K ﹤0.01% 1010

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GPS Wealth Strategies Group's PBYI Position: Q4 2025 in Review

GPS Wealth Strategies Group held its Puma Biotechnology (PBYI) position steady in Q4 2025 at 1,000 shares worth $5.95K. The position accounts for 0.01% of the portfolio, ranked #449.

GPS Wealth Strategies Group first reported a position in PBYI in Q4 2023 and has held it in 9 quarters since. 151 funds tracked by Wall St. Rank hold PBYI as of Q4 2025.

  • GPS Wealth Strategies Group held 1,000 shares of Puma Biotechnology worth $5.95K as of Q4 2025.
  • GPS Wealth Strategies Group left its Puma Biotechnology share count unchanged in Q4 2025.
  • Puma Biotechnology made up 0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #449 holding.
  • GPS Wealth Strategies Group first reported a position in Puma Biotechnology in Q4 2023 and has held it in 9 quarters since.
  • 151 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.